Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 7/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | NOS2 | P35228 | 1/20 | 0.40 |
| ▸ | CTSK | P43235 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MDM4 | O15151 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4346781 | 1.00 | HCAR2 (0.57) | HCAR2POLBNOS2CTSKCA2 | |
| SCHEMBL3676644 | 1.00 | HCAR2 (0.57) | HCAR2POLBNOS2CTSKCA2 | |
| SCHEMBL10711253 | 0.94 | HCAR2 (0.55) | HCAR2ALDH1A1LMNAMAPTZDHHC2 | |
| SCHEMBL10711250 | 0.94 | HCAR2 (0.55) | HCAR2ALDH1A1LMNAMAPTZDHHC2 | |
| SCHEMBL9419967 | 0.91 | HCAR2 (0.60) | HCAR2NOS2ALDH1A1CYP3A4MDM4 | |
| SCHEMBL9419971 | 0.91 | HCAR2 (0.60) | HCAR2NOS2ALDH1A1CYP3A4MDM4 | |
| SCHEMBL9420058 | 0.91 | HCAR2 (0.60) | HCAR2NOS2ALDH1A1CYP3A4MDM4 | |
| SCHEMBL27216283 | 0.85 | HCAR2 (0.64) | HCAR2POLBNOS2ALDH1A1CYP3A4 | |
| SCHEMBL3482642 | 0.85 | HCAR2 (0.64) | HCAR2POLBNOS2ALDH1A1CYP3A4 | |
| SCHEMBL3482700 | 0.85 | HCAR2 (0.64) | HCAR2POLBNOS2ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250154530-A1 | MODIFIED MONOCYTES/MACROPHAGES/DENDRITIC CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND USES IN DISEASES AND DISORDERS ASSOCIATED WITH PROTEIN AGGREGATES | UNIV PENNSYLVANIA (US) | 2025-05-15 | — | — | US | disclosed |
| EP-2119744-B1 | TWO-COMPONENT CURING COMPOSITION | SUNSTAR ENGINEERING INC (JP) | 2019-06-05 | — | — | EP | disclosed |
| US-20100016486-A1 | TWO-COMPONENT HARDENING COMPOSITION | SUNSTAR GIKEN KABUSHIKI KAISHA (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-1655346-B1 | TWO-PART CURABLE COMPOSITION | SUNSTAR ENGINEERING INC (JP) | 2009-12-09 | — | — | EP | disclosed |
| US-7622525-B2 | Two-part curable composition | SUNSTAR GIKEN KABUSHIKI KAISHA (JP) | 2009-11-24 | — | — | US | disclosed |
| EP-2119744-A1 | TWO-COMPONENT HARDENING COMPOSITION | Sunstar Giken Kabushiki Kaisha (JP) | 2009-11-18 | — | — | EP | disclosed |
| US-20060293437-A1 | Two-part curable composition | SUNSTAR GIKEN KABUSHIKI KAISHA (JP) | 2006-12-28 | — | — | US | disclosed |
| EP-1655346-A1 | TWO-PART CURABLE COMPOSITION | SUNSTAR GIKEN KABUSHIKI KAISHA (JP) | 2006-05-10 | — | — | EP | disclosed |